Over the last decade, research and development have increased their efforts into personalized medicine. This involves using laboratory diagnostic testing to find cell, gene, and immunotherapy treatments that are tailored to the subject. The latest research and development are making breakthroughs in treating diseases that occur from genetic mutations. It is one of the most effective ways to determine precisely the best treatments for a person’s unique genetic makeup.
DoseID, the first of its kind industry consortium for best practices in RFID use in healthcare, announced its founding board of directors. DoseID brings industry players from across the healthcare continuum together to ensure RFID quality, performance, and interoperability for drug products.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.